ABBV: AbbVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 139,018.60
Book Value ($M) -7,826.00
Book Value / Share -5.29
Price / Book -13.91
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.08
Return on Equity (ROE) 1.12

Liquidity (mrq)
Quick Ratio 0.91
Current Ratio 1.04

Balance Sheet (mrq) ($M)
Current Assets 14,413.00
Assets 56,769.00
Liabilities 64,595.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 32,753.00
Operating Income 6,383.00
Net Income 5,687.00
Earnings Per Share Basic 3.67
Earnings Per Share Diluted 3.66

Cash Flow Statement (mra) ($M)
Cash From Operations 13,427.00
Cash from Investing -1,006.00
Cash from Financing 13,427.00

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-14 13G/A Capital Research Global Investors 11.50 0.00
2019-02-14 13G/A Vanguard Group Inc 8.01
2019-02-04 13G/A BlackRock Inc. 6.40 -5.46

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-08-05 10-Q ABBV / AbbVie Inc. 10-Q – Quarterly Report – 10-Q
2019-05-03 10-Q ABBV / AbbVie Inc. 10-Q Quarterly Report 10-Q
2019-02-27 10-K ABBV / AbbVie Inc. 10-K (Annual Report)
2018-11-07 10-Q ABBV / AbbVie Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
ABT – Abbott Laboratories AGN – Allergan plc


Financial data and stock pages provided by
Fintel.io